138 related articles for article (PubMed ID: 30136313)
21. The added value of PMS2 immunostaining in the diagnosis of hereditary nonpolyposis colorectal cancer.
Halvarsson B; Lindblom A; Rambech E; Lagerstedt K; Nilbert M
Fam Cancer; 2006; 5(4):353-8. PubMed ID: 16817031
[TBL] [Abstract][Full Text] [Related]
22. SMARCAD1-mediated recruitment of the DNA mismatch repair protein MutLα to MutSα on damaged chromatin induces apoptosis in human cells.
Takeishi Y; Fujikane R; Rikitake M; Obayashi Y; Sekiguchi M; Hidaka M
J Biol Chem; 2020 Jan; 295(4):1056-1065. PubMed ID: 31843968
[TBL] [Abstract][Full Text] [Related]
23. DNA mismatch repair deficiency in breast carcinoma: a pilot study of triple-negative and non-triple-negative tumors.
Wen YH; Brogi E; Zeng Z; Akram M; Catalano J; Paty PB; Norton L; Shia J
Am J Surg Pathol; 2012 Nov; 36(11):1700-8. PubMed ID: 22992699
[TBL] [Abstract][Full Text] [Related]
24. Human MutLγ, the MLH1-MLH3 heterodimer, is an endonuclease that promotes DNA expansion.
Kadyrova LY; Gujar V; Burdett V; Modrich PL; Kadyrov FA
Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3535-3542. PubMed ID: 32015124
[TBL] [Abstract][Full Text] [Related]
25. Stable expression of MutLγ in human cells reveals no specific response to mismatched DNA, but distinct recruitment to damage sites.
Roesner LM; Mielke C; Fähnrich S; Merkhoffer Y; Dittmar KE; Drexler HG; Dirks WG
J Cell Biochem; 2013 Oct; 114(10):2405-14. PubMed ID: 23696135
[TBL] [Abstract][Full Text] [Related]
26. A novel interaction between human DNA polymerase eta and MutLalpha.
Kanao R; Hanaoka F; Masutani C
Biochem Biophys Res Commun; 2009 Nov; 389(1):40-5. PubMed ID: 19703417
[TBL] [Abstract][Full Text] [Related]
27. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
[TBL] [Abstract][Full Text] [Related]
28. Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer.
Nyström-Lahti M; Perrera C; Räschle M; Panyushkina-Seiler E; Marra G; Curci A; Quaresima B; Costanzo F; D'Urso M; Venuta S; Jiricny J
Genes Chromosomes Cancer; 2002 Feb; 33(2):160-7. PubMed ID: 11793442
[TBL] [Abstract][Full Text] [Related]
29. Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters.
Hashmi AA; Ali R; Hussain ZF; Faridi N; Khan EY; Bakar SMA; Edhi MM; Khan M
World J Surg Oncol; 2017 Jun; 15(1):116. PubMed ID: 28651545
[TBL] [Abstract][Full Text] [Related]
30. Frequent Mismatch Repair Protein Deficiency in Mixed Endometrioid and Clear Cell Carcinoma of the Endometrium.
Köbel M; Tessier-Cloutier B; Leo J; Hoang LN; Gilks CB; Soslow RA; Delair D; Stewart CJR; Lee CH
Int J Gynecol Pathol; 2017 Nov; 36(6):555-561. PubMed ID: 28114191
[TBL] [Abstract][Full Text] [Related]
31. The PMS2 subunit of human MutLalpha contains a metal ion binding domain of the iron-dependent repressor protein family.
Kosinski J; Plotz G; Guarné A; Bujnicki JM; Friedhoff P
J Mol Biol; 2008 Oct; 382(3):610-27. PubMed ID: 18619468
[TBL] [Abstract][Full Text] [Related]
32. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
[TBL] [Abstract][Full Text] [Related]
33. Dynamic human MutSα-MutLα complexes compact mismatched DNA.
Bradford KC; Wilkins H; Hao P; Li ZM; Wang B; Burke D; Wu D; Smith AE; Spaller L; Du C; Gauer JW; Chan E; Hsieh P; Weninger KR; Erie DA
Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16302-16312. PubMed ID: 32586954
[TBL] [Abstract][Full Text] [Related]
34. Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.
Rigter LS; Snaebjornsson P; Rosenberg EH; Atmodimedjo PN; Aleman BM; Ten Hoeve J; Geurts-Giele WR; ; van Ravesteyn TW; Hoeksel J; Meijer GA; Te Riele H; van Leeuwen FE; Dinjens WN; van Leerdam ME
Gut; 2018 Mar; 67(3):447-455. PubMed ID: 29439113
[TBL] [Abstract][Full Text] [Related]
35. Mismatch repair pathway: molecules, functions, and role in colorectal carcinogenesis.
Sameer AS; Nissar S; Fatima K
Eur J Cancer Prev; 2014 Jul; 23(4):246-57. PubMed ID: 24614649
[TBL] [Abstract][Full Text] [Related]
36. Different mutator phenotypes in Mlh1- versus Pms2-deficient mice.
Yao X; Buermeyer AB; Narayanan L; Tran D; Baker SM; Prolla TA; Glazer PM; Liskay RM; Arnheim N
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6850-5. PubMed ID: 10359802
[TBL] [Abstract][Full Text] [Related]
37. Mismatch repair deficiency in Lynch syndrome-associated colorectal adenomas is more prevalent in older patients.
Tanaka M; Nakajima T; Sugano K; Yoshida T; Taniguchi H; Kanemitsu Y; Nagino M; Sekine S
Histopathology; 2016 Aug; 69(2):322-8. PubMed ID: 26826556
[TBL] [Abstract][Full Text] [Related]
38. Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer.
Norris AM; Woodruff RD; D'Agostino RB; Clodfelter JE; Scarpinato KD
Prostate; 2007 Feb; 67(2):214-25. PubMed ID: 17044039
[TBL] [Abstract][Full Text] [Related]
39. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.
Jessup CJ; Redston M; Tilton E; Reimann JD
Hum Pathol; 2016 Mar; 49():1-9. PubMed ID: 26826402
[TBL] [Abstract][Full Text] [Related]
40. Validation of an in Vitro Mismatch Repair Assay Used in the Functional Characterization of Mismatch Repair Variants.
González-Acosta M; Hinrichsen I; Fernández A; Lázaro C; Pineda M; Plotz G; Capellá G
J Mol Diagn; 2020 Mar; 22(3):376-385. PubMed ID: 31881334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
